Gould Robert J
Fulcrum Therapeutics, Inc. · Director
Gould Robert J is listed in filings as Director at Fulcrum Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Fulcrum Therapeutics, Inc. (FULC). The current snapshot covers public activity from Jun 18, 2024 to Feb 4, 2026. Reported amounts are shown as $160.9K to $163.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $161k15k shares | SellFeb 2, 2026 | $10.72 | $3.50 |